Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.
Ravandi F, Subklewe M, Walter RB, Vachhani P, Ossenkoppele G, Buecklein V, Döhner H, Jongen-Lavrencic M, Baldus CD, Fransecky L, Pardee TS, Kantarjian H, Yen PK, Mukundan L, Panwar B, Yago MR, Agarwal S, Khaldoyanidi SK, Stein A.
Ravandi F, et al. Among authors: stein a.
Leuk Lymphoma. 2024 May 7:1-11. doi: 10.1080/10428194.2024.2346755. Online ahead of print.
Leuk Lymphoma. 2024.
PMID: 38712673